Peer-reviewed veterinary case report
Structural Basis for how Sialoglycan-binding Viridans Streptococci Accommodate Ligands that Exceed the Characterized Binding Site.
- Year:
- 2026
- Authors:
- Morrison KM et al.
- Affiliation:
- Department of Pharmacology
Abstract
During endocardial infections, viridans group streptococci use proteins containing siglec-like binding regions to engage sialic acid-capped <i>O-</i> GalNAc glycans on platelet glycoprotein GPIbα. Much past work used isolated di-, tri-, or tetrasaccharide partial ligands to interrogate this sialoglycan binding. Here, we report the 1.9 Å resolution crystal structure of the <i>Streptococcus gordonii</i> strain M99 siglec-like binding region bound to an L-serine-linked sialyl T antigen (sTa) trisaccharide. The structure demonstrates how trisaccharide extensions are accommodated, with implications for binding larger sialoglycan ligands.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/41573671